Celldex Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 248.99B |
| FY2017 | 19.08B |
| FY2018 | 24.70B |
| FY2019 | 30.0M |
| FY2020 | 30.6M |
| FY2021 | 44.3M |
| FY2022 | 48.4M |
| FY2023 | 48.4M |
| FY2024 | 64.4M |
| FY2025 | 66.4M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 248.99B |
| FY2017 | 19.08B |
| FY2018 | 24.70B |
| FY2019 | 30.0M |
| FY2020 | 30.6M |
| FY2021 | 44.3M |
| FY2022 | 48.4M |
| FY2023 | 48.4M |
| FY2024 | 64.4M |
| FY2025 | 66.4M |